Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VUUGBP

(VUUGBP)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
07/29/20247:05AMBusiness WireAspen Appoints Christian Dunleavy as Group President and Mark Pickering as Group Chief Financial Officer & TreasurerASX:AHLAdrad Holdings Ltd
07/29/20247:04AMBusiness WireLegalShield Workplace Study Unearths Gaps in Employee-Employer Expectations About Benefits Value, Communication
07/29/20247:03AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]AMEX:CANFCan Fite BioPharma Ltd
07/29/20247:03AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PMPhilip Morris International Inc
07/29/20247:03AMPR Newswire (US)Taylor Morrison and Extreme Makeover: Home Edition Enlist Community Volunteers to Help Build New Home for Local Houston FamilyNYSE:TMHCTaylor Morrison Home Holding Company
07/29/20247:02AMAlliance NewsAlliance NewsLONDON MARKET MIDDAY: Stocks rise but BoE cut hopes temper pound
07/29/20247:02AMGlobeNewswire Inc.Ocugen to Host Conference Call on Thursday, August 8 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2024 Financial ResultsNASDAQ:OCGNOcugen Inc
07/29/20247:02AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:OISOil States International Inc
07/29/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:MCDMcDonalds Corp
07/29/20247:01AMAlliance NewsAlliance NewsIN BRIEF: Concurrent Technologies launches new Plug In CardLSE:CNCConcurrent Technologies Plc
07/29/20247:01AMGlobeNewswire Inc.LuxUrban Hotels Announces Agreement in Principle to Issue Up to $5.0 Million Senior Notes Due 2027NASDAQ:LUXHLuxUrban Hotels Inc
07/29/20247:01AMBusiness WireRapid Finance Adds Matthew Thomas as Enterprise Account Executive
07/29/20247:01AMPR Newswire (US)Syndax Announces PDUFA Action Date Extension for Revumenib NDA for Relapsed or Refractory KMT2Ar Acute LeukemiaNASDAQ:SNDXSyndax Pharmaceuticals Inc
07/29/20247:01AMPR Newswire (US)Leading Midsize Agency, /prompt. Announces Significant Investment in Augmented Intelligence-Powered Strategy Team
07/29/20247:01AMPR Newswire (US)Tech Mahindra Positioned as a Service Leader in the 2024 SPARK Matrix™ Contact Center Outsourcing Services by Quadrant Knowledge Solutions
07/29/20247:00AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:CVMCel Sci Corporation New
07/29/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:PKSTPeakstone Realty Trust
07/29/20247:00AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MSGMMotorsport Games Inc
07/29/20247:00AMGlobeNewswire Inc.AMG Reports Financial and Operating Results for the Second Quarter and First Half of 2024NYSE:AMGAffiliated Managers Group Inc
07/29/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CGENCompugen Ltd
07/29/20247:00AMBusiness WireParticular Audience Named in The Leading 100 List, Setting a New Standard in AI-Driven Hyper-Personalization for eCommerce & Retail Media
07/29/20247:00AMGlobeNewswire Inc.Manhattan Bridge Capital, Inc. Declares Quarterly DividendNASDAQ:LOANManhattan Bridge Capital Inc
07/29/20247:00AMBusiness WireNOG Provides Shareholder Return Update; Plans Mid-Year Increase to Quarterly DividendNYSE:NOGNorthern Oil and Gas Inc
07/29/20247:00AMBusiness WireSarepta Therapeutics to Announce Second Quarter 2024 Financial ResultsNASDAQ:SRPTSarepta Therapeutics Inc New
07/29/20247:00AMGlobeNewswire Inc.ECARX Announces Board ChangeNASDAQ:ECXECARX Holdings Inc
07/29/20247:00AMBusiness WireVirginia State Parks Becomes First in the Nation to Install EnChroma-adapted Viewfinders for Colorblind Guests at Every Park
07/29/20247:00AMGlobeNewswire Inc.CorVascular’s VasoGuard® Earns FDA 510(k) Clearance
07/29/20247:00AMBusiness WireMyrobalan Therapeutics Names Grant Bogle to Board of Directors
07/29/20247:00AMBusiness WireGoldenTree Asset Management Hires Head of Real Estate Credit Origination
07/29/20247:00AMGlobeNewswire Inc.Attralus Receives European Medicines Agency Committee for Orphan Medicinal Products (COMP) Positive Opinions for AT-02 for the Treatment of Both ATTR and AL Amyloidosis

Your Recent History

Delayed Upgrade Clock